Document is current
Any future updates will be listed below
-
Authors
Zhu, Jinhong
Zhang, Jinfeng
Ling, Xiaodong
Wang, Changhong
Yang, Yingnan
Xin, Yangzhong
Jiang, Hao
Liang, Hao
Zhang, Luquan
Qin, Xionghai
Lei, Jingle
Fang, Chengyuan
Yang, Xinxin
Wang, Yuning
Meng, Wei
Wang, Xiaoyuan
Meng, Hongxue
Ma, Jianqun
-
Funding
Funding for this research was provided by:
heilongjiang Provincial Natural Science Foundation of China (ZD2024H003)
Beijing Xisike Clinical Oncology Research Foundation (Y-2024AZ(EGFR) MS-0187)
National Medical High Level Talent Program
Heilongjiang Province Innovation Base Award Project (JD2023SJ03)
Nn10 Project of Harbin Medical University Cancer Hospital (Nn102024-05)
National Natural Science Foundation of China (82573679)
National Key Research and Development Program of China (2024ZD0520904)
Climbing Program of Harbin Medical University Cancer Hospital (PDYS2024-02)
- License Information
-
More Information
Article History
Received: 30 October 2025
Accepted: 18 December 2025
First Online: 28 December 2025
Declarations
:
: The study protocol has been approved by the China Ethics Committee of Registering Clinical Trials (ChiECRCT20210128). All patients or their legal surrogates provided written informed consent before participating in the study.
: Informed consent was obtained from all patients’ legal surrogates.
: The authors declare no competing interests.
